Clinical trial
Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis
NCT00458614 · Arkansas Children's Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00458614 |
|---|---|
| Title | Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis |
| Official title | Lansoprazole Disposition in Young Children With Cystic Fibrosis |
| Lead sponsor | Arkansas Children's Hospital Research Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Lansoprazole |
| Enrollment | 18 |
| Start date | Jun 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Apr 11, 2007 |
| Last update posted | Jan 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: